4/A//SEC Filing
Reynoso Jamie L. 4/A
Accession 0001839066-25-000008
CIK 0001801170other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:00 PM ET
Size
6.4 KB
Accession
0001839066-25-000008
Insider Transaction Report
Form 4/AAmended
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
- Tax Payment
Class A Common Stock
2025-06-30$2.79/sh−85,596$238,813→ 2,887,905 total
Footnotes (3)
- [F1]This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below.
- [F2]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025.
- [F3]Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839066
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:00 PM ET
- Size
- 6.4 KB